TICKERNOMICS Sign up
Last Update: 2024-12-27 15:29:36
BioCardia Inc. ( BCDA ) https://www.biocardia.com
2.32USD
Sector:
Healthcare
Industry:
Biotechnology
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
27.80%
-76.39%
BCDA
SPY
32.66%
-93.16%
BCDA
SPY
108.59%
-95.85%
BCDA
SPY
302.52%
-98.64%
BCDA
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
6.56
2.67
0.21
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.85
15.33
2.38
-141.20
0.00
-0.36
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-58533.33
-3433.33
-11512.50
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
8.2576
-204.17
-266.19
1.07
Other Earnings and Cash Flow Stats:
BioCardia Inc. ( BCDA ) Net Income TTM ($MM) is -7.72
BioCardia Inc. ( BCDA ) Operating Income TTM ($MM) is -7.76
BioCardia Inc. ( BCDA ) Owners' Earnings Annual ($MM) is 0.00
BioCardia Inc. ( BCDA ) Current Price to Owners' Earnings ratio is 0.00
BioCardia Inc. ( BCDA ) EBITDA TTM ($MM) is -7.69
BioCardia Inc. ( BCDA ) EBITDA Margin is -11512.50%
Capital Allocation:
BioCardia Inc. ( BCDA ) has paid 0.00 dividends per share and bought back -1.386448 million shares in the past 12 months
BioCardia Inc. ( BCDA ) has reduced its debt by 0.353 million USD in the last 12 months
Capital Structure:
BioCardia Inc. ( BCDA ) Interest-bearing Debt ($MM) as of last quarter is 1
BioCardia Inc. ( BCDA ) Annual Working Capital Investments ($MM) are 1
BioCardia Inc. ( BCDA ) Book Value ($MM) as of last quarter is 2
BioCardia Inc. ( BCDA ) Debt/Capital as of last quarter is 37%
Other Balance Sheet Stats:
BioCardia Inc. ( BCDA ) has 4 million in cash on hand as of last quarter
BioCardia Inc. ( BCDA ) has 2 million of liabilities due within 12 months, and long term debt 0 as of last quarter
BioCardia Inc. ( BCDA ) has 2 common shares outstanding as of last quarter
BioCardia Inc. ( BCDA ) has 0 million USD of preferred stock value
Academic Scores:
BioCardia Inc. ( BCDA ) Altman Z-Score is -37.62 as of last quarter
BioCardia Inc. ( BCDA ) Piotroski Score is 1.00 as of last quarter
Corporate Governance:
BioCardia Inc. ( BCDA ) largest shareholder is owning shares at 0.00 ($MM) value
Altman Peter(an insider) Bought 250 shares of BioCardia Inc. ( BCDA ) for the amount of $555.00 on 2024-12-05
14.07% of BioCardia Inc. ( BCDA ) is held by insiders, and 2.21% is held by institutions
BioCardia Inc. ( BCDA ) went public on 2008-03-14
Other BioCardia Inc. ( BCDA ) financial metrics:
FCF:-7.31
Unlevered Free Cash Flow:0.00
EPS:-2.46
Operating Margin:-58533.33
Gross Profit Margin:-3433.33
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:-252.38
Beta:1.07
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About BioCardia Inc. ( BCDA ) :
BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.